<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00976482</url>
  </required_header>
  <id_info>
    <org_study_id>07-09</org_study_id>
    <nct_id>NCT00976482</nct_id>
  </id_info>
  <brief_title>Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications</brief_title>
  <acronym>OPTI-MIND</acronym>
  <official_title>Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to collect mid-term clinical outcome in a group of patients implanted
      with permanent pacemaker (PM) according to real-life clinical practice in a multicenter and
      international environment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The principal objective of the OPTI-MIND study is to collect data on two-year all-cause
      mortality in a general population implanted with a PM according to current clinical practice.
      Additionally, the study aims to stratify the outcome by both known patient-related risk
      factors and by physiologic pacing mode setting (a specifically defined PM programming).
      Stratification will be done for pre-specified classes of patients on the basis of their
      primary rhythm disease.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Two-year All-cause Mortality</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1745</enrollment>
  <condition>Bradyarrhythmia</condition>
  <arm_group>
    <arm_group_label>Pacemaker</arm_group_label>
    <description>Patients currently implanted with permanent Pacemaker according to guidelines</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patient implanted with permanent pacemaker accroding to guidelines.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients implanted with a current Boston Scientific pacemaker (all ALTRUA models) or
             any future commercially available Boston Scientific PM families according to
             international and local guidelines for pacemaker implantation;

          -  Patients who are willing and capable of providing informed consent, participating in
             all testing associated with this clinical investigation at an approved clinical
             investigational centre;

          -  Patients whose age is 18 years or above, or of legal age to give informed consent
             specific to state and national law.

        Exclusion Criteria:

          -  Unable to be followed up by the participating centres for a period of two years;

          -  Current device implanted for more than 15 days;

          -  Women of childbearing potential who are, or plan to become, pregnant during the time
             of the study (method of assessment upon physician's discretion);

          -  Patients who are currently enrolled in another investigational study or registry that
             would directly interfere with the current study, except when the patient is
             participating in a mandatory governmental registry or extensions/amendments of the
             current protocol. Each instance should be brought to the attention of the sponsor to
             determine eligibility.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauro Biffi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Az. Osp. S. orsola - Malpighi, Bologna, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Katholisches Krankenhaus, St.Johannes Hospital</name>
      <address>
        <city>Hagen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2009</study_first_submitted>
  <study_first_submitted_qc>September 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2009</study_first_posted>
  <results_first_submitted>March 15, 2015</results_first_submitted>
  <results_first_submitted_qc>October 10, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 2, 2016</results_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular</keyword>
  <keyword>Pacemaker</keyword>
  <keyword>Mortality</keyword>
  <keyword>Physiologic pacing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pacemaker</title>
          <description>Patients currently implanted with permanent Pacemaker according to guidelines</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1745"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Eligible for Last Follow up</title>
              <participants_list>
                <participants group_id="P1" count="1487"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1486"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="259"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="208"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Center terminated</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>among the 1745 initial patients 5 were excluded for inclusion criteria violations (deviations from correct signature of informed consent)</population>
      <group_list>
        <group group_id="B1">
          <title>Pacemaker</title>
          <description>Patients currently implanted with permanent Pacemaker according to guidelines</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1740"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1047"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="693"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary Indication for Permanent Pacing</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>sinus node dysfunction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="565"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Atrioventricular Block</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="840"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neuro-mediated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Permanent AF with Slow Ventr. Response</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="274"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Two-year All-cause Mortality</title>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pacemaker</title>
            <description>Patients currently implanted with permanent Pacemaker according to guidelines</description>
          </group>
        </group_list>
        <measure>
          <title>Two-year All-cause Mortality</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1740"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="9.3" upper_limit="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Pacemaker</title>
          <description>implanted Patients</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="611" subjects_at_risk="1740"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>disease progression leading to death</sub_title>
                <counts group_id="E1" events="208" subjects_affected="208" subjects_at_risk="1740"/>
              </event>
              <event>
                <sub_title>leading to invasive interventions</sub_title>
                <counts group_id="E1" events="632" subjects_affected="403" subjects_at_risk="1740"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="206" subjects_at_risk="1740"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="206" subjects_at_risk="1740"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>dr Mauro Biffi</name_or_title>
      <organization>ospedale S Orsola- Malpighi, Bologna, Italy</organization>
      <phone>+393337661449</phone>
      <email>mauro.biffi@aosp.bo.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

